Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source

Source document· January 19, 2026

Beat the Market the Zacks Way: Amicus, Micron, Amgen in Focus

Beat the Market the Zacks Way: Amicus, Micron, Amgen in Focus Last Friday, the three most widely followed benchmark indexes closed a losing week…

Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

Over the 10-year period (2016 through 2025), the portfolio of equal-weight Zacks Rank #1 stocks outperformed the equal-weight S&P 500 index by more than 7 percentage points (+18.55% vs. +11.65%)
80% confidence
An equal-weight portfolio of Zacks Rank #1 (Strong Buy) stocks outperformed the equal-weight S&P 500 index by 7 percentage points (+17.81% vs. +10.85%)
80% confidence
The hypothetical equal-weight portfolio of Zacks Rank #1 stocks returned +22.4% in 2024 vs. +13.7% for the equal-weight S&P 500 index
80% confidence
Investor sentiment was affected by a mix of tariff-related trade war fears and uncertainty about economic policy
80% confidence
Tariff jitters prompted safe-haven flows into gold and pushed markets to price in heightened geopolitical risk
80% confidence